The short read sequencing market size has grown rapidly in recent years. It will grow from $7.8 billion in 2025 to $9.2 billion in 2026 at a compound annual growth rate (CAGR) of 17.9%. The growth in the historic period can be attributed to expansion of genomics research initiatives, declining cost per genome sequencing, increased use of NGS in academic research, growth of population-scale sequencing studies, wider availability of sequencing instruments.
The short read sequencing market size is expected to see rapid growth in the next few years. It will grow to $17.75 billion in 2030 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increasing adoption of precision medicine programs, rising demand for oncology and rare disease sequencing, expansion of clinical diagnostics using NGS, growing investments in genomics data infrastructure, increasing use of AI-driven sequence analysis. Major trends in the forecast period include increasing adoption of high-throughput sequencing platforms, rising demand for cost-effective whole genome sequencing, growing integration of advanced bioinformatics pipelines, expansion of clinical and translational genomics applications, enhanced focus on sequencing accuracy and speed.
The increasing adoption of personalized medicine is driving growth in the short-read sequencing market. Personalized medicine customizes medical treatment according to an individual’s genetic profile, enabling more precise and effective healthcare interventions. Short-read sequencing is critical for detecting genetic variations that influence drug response, supporting the development of tailored treatment plans. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the US FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the growing adoption of personalized medicine is boosting the short-read sequencing market.
Major companies in the short-read sequencing market are focusing on innovations such as hybrid long-/short-read sequencing assays to enhance analytical capabilities and improve access to complex genomic regions. A hybrid long-/short-read sequencing assay combines the generation of long and short sequencing reads on a single platform, providing higher genomic resolution while remaining compatible with standard high-throughput systems. For instance, in March 2023, Illumina Inc., a US-based provider of DNA sequencing and array-based technologies, launched the Illumina Complete Long Read Prep, Human assay. This product integrates long-read capability into existing short-read sequencing instruments, enabling laboratories to capture comprehensive genomic data without separate long-read systems. It supports low DNA input requirements and maintains high accuracy, improving the analysis of difficult-to-map genomic regions while simplifying workflows.
In March 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, including short-read sequencing, formed a partnership with Sophia Genetics SA. This collaboration aims to enhance next-generation sequencing (NGS) capabilities by integrating QIAGEN's QIAseq reagent technology with SOPHiA's DDM (Digital Data Management) platform, facilitating improved tumor analysis and somatic variant detection. Sophia Genetics SA is a Switzerland-based company specializing in medical software.
Major companies operating in the short read sequencing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, BGI Genomics Co Ltd, MGI Tech Co. Ltd., 10x Genomics Inc., Zymo Research Corporation, Paragon Genomics Inc., Novogene Co. Ltd, Macrogen Inc., Fasteris SA, GenScript Biotech Corporation, Element Biosciences Inc., Singular Genomics Systems Inc., Ultima Genomics Inc., GenapSys Inc.
North America was the largest region in the Short Read Sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the short read sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the short read sequencing market by increasing costs of imported sequencing instruments, optical components, reagents, flow cells, and data processing hardware. Research institutions and clinical laboratories in North America and Europe are most affected due to dependence on imported high-end sequencing systems, while Asia-Pacific faces pricing pressure on consumables supply. These tariffs are raising operational costs and slowing procurement of new platforms. However, they are also encouraging local manufacturing of sequencing consumables, regional supply chain diversification, and investment in domestic genomics infrastructure.
The short read sequencing market research report is one of a series of new reports that provides short read sequencing market statistics, including short read sequencing industry global market size, regional shares, competitors with a short read sequencing market share, detailed short read sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the short read sequencing industry. This short read sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Short-read sequencing, also known as next-generation sequencing (NGS), is a high-throughput DNA sequencing technique that produces short fragments or reads of DNA sequences. It has revolutionized genomics by facilitating the rapid and cost-effective analysis of entire genomes and transcriptomes.
The primary product categories in short-read sequencing comprise instruments, consumables, and services. Short-read sequencing instruments are the platforms or machines employed to generate short DNA fragments for analysis, allowing for the identification of genetic variations, mutations, and gene expression levels. Various technologies, including next-generation sequencing and Sanger sequencing, are utilized in workflows such as pre-sequencing, sequencing, and data analysis. These applications find use in clinical investigation, oncology, reproductive health, consumer genomics, agri genomics, forensics, HLA typing, and immune system monitoring. End users of short-read sequencing encompass academic research, hospitals and clinics, clinical research, and pharmaceutical and biotechnology companies.
The short-read sequencing market includes revenues earned by entities by providing short-read sequencing services such as sequencing services, bioinformatics, sample processing, sequencing runs, data generation, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The short-read sequencing market also consists of sales-related products such as sequencing instruments, reagents, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The short read sequencing market size is expected to see rapid growth in the next few years. It will grow to $17.75 billion in 2030 at a compound annual growth rate (CAGR) of 17.9%. The growth in the forecast period can be attributed to increasing adoption of precision medicine programs, rising demand for oncology and rare disease sequencing, expansion of clinical diagnostics using NGS, growing investments in genomics data infrastructure, increasing use of AI-driven sequence analysis. Major trends in the forecast period include increasing adoption of high-throughput sequencing platforms, rising demand for cost-effective whole genome sequencing, growing integration of advanced bioinformatics pipelines, expansion of clinical and translational genomics applications, enhanced focus on sequencing accuracy and speed.
The increasing adoption of personalized medicine is driving growth in the short-read sequencing market. Personalized medicine customizes medical treatment according to an individual’s genetic profile, enabling more precise and effective healthcare interventions. Short-read sequencing is critical for detecting genetic variations that influence drug response, supporting the development of tailored treatment plans. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based nonprofit organization, the US FDA approved 16 new personalized treatments for rare disease patients in 2023, up from six approvals in 2022. Therefore, the growing adoption of personalized medicine is boosting the short-read sequencing market.
Major companies in the short-read sequencing market are focusing on innovations such as hybrid long-/short-read sequencing assays to enhance analytical capabilities and improve access to complex genomic regions. A hybrid long-/short-read sequencing assay combines the generation of long and short sequencing reads on a single platform, providing higher genomic resolution while remaining compatible with standard high-throughput systems. For instance, in March 2023, Illumina Inc., a US-based provider of DNA sequencing and array-based technologies, launched the Illumina Complete Long Read Prep, Human assay. This product integrates long-read capability into existing short-read sequencing instruments, enabling laboratories to capture comprehensive genomic data without separate long-read systems. It supports low DNA input requirements and maintains high accuracy, improving the analysis of difficult-to-map genomic regions while simplifying workflows.
In March 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, including short-read sequencing, formed a partnership with Sophia Genetics SA. This collaboration aims to enhance next-generation sequencing (NGS) capabilities by integrating QIAGEN's QIAseq reagent technology with SOPHiA's DDM (Digital Data Management) platform, facilitating improved tumor analysis and somatic variant detection. Sophia Genetics SA is a Switzerland-based company specializing in medical software.
Major companies operating in the short read sequencing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN N.V., PerkinElmer Inc., Eurofins Scientific SE, BGI Genomics Co Ltd, MGI Tech Co. Ltd., 10x Genomics Inc., Zymo Research Corporation, Paragon Genomics Inc., Novogene Co. Ltd, Macrogen Inc., Fasteris SA, GenScript Biotech Corporation, Element Biosciences Inc., Singular Genomics Systems Inc., Ultima Genomics Inc., GenapSys Inc.
North America was the largest region in the Short Read Sequencing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the short read sequencing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the short read sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the short read sequencing market by increasing costs of imported sequencing instruments, optical components, reagents, flow cells, and data processing hardware. Research institutions and clinical laboratories in North America and Europe are most affected due to dependence on imported high-end sequencing systems, while Asia-Pacific faces pricing pressure on consumables supply. These tariffs are raising operational costs and slowing procurement of new platforms. However, they are also encouraging local manufacturing of sequencing consumables, regional supply chain diversification, and investment in domestic genomics infrastructure.
The short read sequencing market research report is one of a series of new reports that provides short read sequencing market statistics, including short read sequencing industry global market size, regional shares, competitors with a short read sequencing market share, detailed short read sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the short read sequencing industry. This short read sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Short-read sequencing, also known as next-generation sequencing (NGS), is a high-throughput DNA sequencing technique that produces short fragments or reads of DNA sequences. It has revolutionized genomics by facilitating the rapid and cost-effective analysis of entire genomes and transcriptomes.
The primary product categories in short-read sequencing comprise instruments, consumables, and services. Short-read sequencing instruments are the platforms or machines employed to generate short DNA fragments for analysis, allowing for the identification of genetic variations, mutations, and gene expression levels. Various technologies, including next-generation sequencing and Sanger sequencing, are utilized in workflows such as pre-sequencing, sequencing, and data analysis. These applications find use in clinical investigation, oncology, reproductive health, consumer genomics, agri genomics, forensics, HLA typing, and immune system monitoring. End users of short-read sequencing encompass academic research, hospitals and clinics, clinical research, and pharmaceutical and biotechnology companies.
The short-read sequencing market includes revenues earned by entities by providing short-read sequencing services such as sequencing services, bioinformatics, sample processing, sequencing runs, data generation, and analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The short-read sequencing market also consists of sales-related products such as sequencing instruments, reagents, and consumables. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Short Read Sequencing Market Characteristics
3. Short Read Sequencing Market Supply Chain Analysis
4. Global Short Read Sequencing Market Trends and Strategies
5. Short Read Sequencing Market Analysis of End Use Industries
7. Global Short Read Sequencing Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Short Read Sequencing Total Addressable Market (TAM) Analysis for the Market
9. Short Read Sequencing Market Segmentation
10. Short Read Sequencing Market Regional and Country Analysis
11. Asia-Pacific Short Read Sequencing Market
12. China Short Read Sequencing Market
13. India Short Read Sequencing Market
14. Japan Short Read Sequencing Market
15. Australia Short Read Sequencing Market
16. Indonesia Short Read Sequencing Market
17. South Korea Short Read Sequencing Market
18. Taiwan Short Read Sequencing Market
19. South East Asia Short Read Sequencing Market
20. Western Europe Short Read Sequencing Market
21. UK Short Read Sequencing Market
22. Germany Short Read Sequencing Market
23. France Short Read Sequencing Market
24. Italy Short Read Sequencing Market
25. Spain Short Read Sequencing Market
26. Eastern Europe Short Read Sequencing Market
27. Russia Short Read Sequencing Market
28. North America Short Read Sequencing Market
29. USA Short Read Sequencing Market
30. Canada Short Read Sequencing Market
31. South America Short Read Sequencing Market
32. Brazil Short Read Sequencing Market
33. Middle East Short Read Sequencing Market
34. Africa Short Read Sequencing Market
36. Short Read Sequencing Market Competitive Landscape and Company Profiles
37. Short Read Sequencing Market Other Major and Innovative Companies
40. Short Read Sequencing Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Short Read Sequencing Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses short read sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for short read sequencing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The short read sequencing market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Instruments; Consumables; Services2) By Workflow: Pre-Sequencing; Sequencing; Data Analysis
3) By Application: Clinical Investigation; Oncology; Reproductive Health; Consumer Genomics; Agri genomics And Forensics; HLA Typing Or Immune System Monitoring
4) By End Users: Academic Research; Hospitals And Clinics; Clinical Research; Pharmaceutical And Biotechnology Companies
Subsegments:
1) By Instruments: Next-Generation Sequencing (NGS) Systems; Sequencing Platforms; Library Preparation Systems2) By Consumables: Reagents And Kits; Flow Cells; Sample Preparation Consumables
3) By Services: Sequencing Services; Data Analysis Services; Bioinformatics Services
Companies Mentioned: F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Illumina Inc.; Agilent Technologies Inc.; QIAGEN N.V.; PerkinElmer Inc.; Eurofins Scientific SE; BGI Genomics Co Ltd; MGI Tech Co. Ltd.; 10x Genomics Inc.; Zymo Research Corporation; Paragon Genomics Inc.; Novogene Co. Ltd; Macrogen Inc.; Fasteris SA; GenScript Biotech Corporation; Element Biosciences Inc.; Singular Genomics Systems Inc.; Ultima Genomics Inc.; GenapSys Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Short Read Sequencing market report include:- F. Hoffmann-La Roche AG
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- Agilent Technologies Inc.
- QIAGEN N.V.
- PerkinElmer Inc.
- Eurofins Scientific SE
- BGI Genomics Co Ltd
- MGI Tech Co. Ltd.
- 10x Genomics Inc.
- Zymo Research Corporation
- Paragon Genomics Inc.
- Novogene Co. Ltd
- Macrogen Inc.
- Fasteris SA
- GenScript Biotech Corporation
- Element Biosciences Inc.
- Singular Genomics Systems Inc.
- Ultima Genomics Inc.
- GenapSys Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 9.2 Billion |
| Forecasted Market Value ( USD | $ 17.75 Billion |
| Compound Annual Growth Rate | 17.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
